FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for spironolactone from Mylan Pharmaceuticals Inc., enabling continued marketing of the product and potential labeling u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hyperaldosteronism
• Hypertension
• Liver Cirrhosis with Ascites
• Nephrotic Syndrome

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

SUPPL AP for SPIRONOLACTONE (SPIRONOLACTONE)